SB 1377 Arizona Senate · 57th Legislature - First Regular Session

authorized recipients; donated medicine; information

SB 1377 establishes rules for Arizona healthcare facilities (authorized recipients) to accept and distribute donated medicine from donors like pharmacies or manufacturers. It requires donated medicine to be unopened, properly stored, and meet safety standards (e.g., no adulteration, temperature control), with strict recordkeeping for inventory and disposal. The bill prohibits reselling donated medicine but allows limited handling fees, while protecting good-faith participants from liability. It directly affects healthcare providers receiving donations, donors, and patients who may receive the medicine under specific conditions. The law was signed by the governor in May 2025.

Issues: ✓ Healthcare

Bill status signed all 5 stages cleared

Introduction

Feb 2025

Committee Review

Mar 2025

Senate Passage

Mar 2025

House Passage

Apr 2025

Signed into Law

May 2025

Introduced Feb 3, 2025 Signed May 7, 2025

Maddy AI version diff · 2 comparisons

What changed between versions

Senate Engrossed Version → Chaptered Version · 8 edits

MODERATE

SB 1377 was enacted into law as Chapter 139, adding new substantive provisions to Arizona's donated medicine program. The changes expand the program's scope by adding new requirements for record retention, fee limitations, and public information posting, while also clarifying definitions and liability protections for participants.

Scope change

The bill's scope expanded from basic donation procedures to include comprehensive recordkeeping requirements, fee limitations, public information dissemination obligations, and expanded definitions of eligible entities and patients.

REQUIREMENT

New record retention requirement mandates that all records be kept for at least seven years in physical or electronic format.

Added prohibition on reselling donated medicine, clarifying that handling or administrative fees do not constitute reselling.

New provision requiring authorized recipients to post public information on their websites about donation locations, eligible patients, and access procedures.

Added requirement for authorized recipients to make all records available for audit within five business days of a board request.

DEFINITION

Added comprehensive definitions for 'authorized recipient', 'donor', 'eligible patient', 'health care professional', 'medicine', 'returns processor', and 'unopened, tamper-evident packaging'.

ENFORCEMENT

Expanded immunity provisions to protect donors, authorized recipients, and associated personnel from civil, criminal, or disciplinary liability when acting in good faith.

ELIGIBILITY

Defined 'eligible patient' as individuals who are indigent, uninsured, underinsured, or enrolled in public health benefits programs.

TECHNICAL

Added provision allowing use of identifiers like serial numbers or barcodes in place of certain record or label information if the information remains readily retrievable.

Introduced Version → Senate Engrossed Version · 9 edits · Mar 4, 2025

MAJOR

The bill was reformatted and renumbered from an introduced version to a Senate Engrossed version, with significant substantive additions to the statute. The most important changes include new provisions prohibiting the resale of donated medicine, establishing fee limits for handling and dispensing, adding a seven-year record retention requirement, and expanding definitions of eligible entities and patients. These additions strengthen consumer protections and clarify operational requirements for the donated medicine program.

Scope change

The bill's scope was expanded to include additional operational requirements and definitions that were not present in the introduced version, particularly regarding recordkeeping, resale prohibitions, and fee limitations.

REQUIREMENT

New subsection N prohibits reselling donated medicine and limits fees that authorized recipients may charge for handling, dispensing, or administrative services based on retail cost.

New subsection O requires authorized recipients to comply with federal recordkeeping requirements for nonsaleable returns when processing donated medicine for tax or credit purposes.

New subsection P mandates retention of all required records for at least seven years and allows use of identifiers like serial numbers or barcodes in place of specific information if retrievable.

New subsection Q clarifies that donations are not considered changes of ownership unless specified, and defines how transaction history records should be maintained.

New subsection R requires donors and authorized recipients to make records available for board audits within five business days of request.

DEFINITION

New subsection U defines key terms including authorized recipient, donor, eligible patient, health care professional, medicine, returns processor, and unopened tamper-evident packaging.

New subsection U.V expands the list of entities that may post information about the donation program on their websites to include health profession regulatory boards.

ENFORCEMENT

New subsection S provides immunity from civil, criminal, and disciplinary liability for persons acting in good faith under the donated medicine program.

SCOPE

New subsection T clarifies that the section does not prohibit otherwise legal activities related to nonprescription drugs.

Floor votes · Senate Mar 4, 2025 · House Apr 30, 2025

How they voted

26–1

Passed · 3 other

Total votes 30

Mar 4, 2025

D Democratic13

10 Yea 1 Nay 2

76% Yea

R Republican17

16 Yea 1

94% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

May 7, 2025

Signed into law

Signed by Governor

executive

Apr 30, 2025

Lower · Passed

PASSED

lower

Apr 3, 2025

Lower · Passed

lower

Mar 24, 2025

Lower · Passed

lower

Mar 4, 2025

Upper · Passed

PASSED

upper

Feb 27, 2025

Upper · Passed

DPA

upper

Feb 12, 2025

Upper · Passed

DPA

upper

1 primary · 0 co-sponsors